Advent Life Sciences
Overview
Advent Life Sciences is a venture capital firm dedicated to investing in life sciences businesses . Focusing on innovative companies in biotechnology, pharmaceuticals, medical devices, and diagnostics, Advent Life Sciences supports the development of breakthrough technologies and therapies . By providing capital and strategic expertise, the firm helps entrepreneurs navigate the complexities of the life sciences sector, accelerating the path from research to market . Advent Life Sciences is committed to advancing healthcare solutions that improve patient outcomes and address unmet medical needs globally . They invest in early and mid-stage companies with a first-in-class or best-in-class approach . Their investments are focused on new drug discovery, including small molecules, biologics, and new modalities, as well as med tech, enabling technologies, and vaccines .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Beacon Therapeutics | Jan 2026 | Series C | Co-investor |
| Cyted Health | Aug 2025 | Series B | Lead |
| Glycomine | Apr 2025 | Series C | Lead |
| Epitopea | Oct 2024 | Pre Seed | Co-investor |
| Epitop | Oct 2024 | VC Round | Co-investor |
Key People
Raj Parekh
General Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.